AbbVie Income Statement
ABBV / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
AbbVie reported $61.2B in revenue and $4.2B in net income for FY2025. Revenue has grown at a 9.4% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $61.2B | $56.3B | $54.3B | $58.1B | $56.2B | $45.8B | $33.3B | $32.8B | $28.2B | $25.6B | $22.9B | $20.0B | $18.8B | $18.4B | $17.4B |
| Cost of Revenue | $18.2B | $16.9B | $20.4B | $17.4B | $17.4B | $15.4B | $7.4B | $7.7B | $7.0B | $5.8B | $4.5B | $4.4B | $4.6B | $4.5B | $4.6B |
| Gross Profit | - | - | - | - | - | - | - | $6.0B | $4.9B | $4.6B | $4.1B | $3.5B | $3.2B | - | - |
| SG&A Expense | $14.0B | $14.8B | $12.9B | $15.3B | $12.3B | $11.3B | $6.9B | $7.4B | $6.3B | $5.9B | $6.4B | $7.7B | $5.4B | $5.0B | $5.9B |
| R&D Expense | $9.1B | $12.8B | $7.7B | $6.5B | $6.9B | $6.4B | $6.4B | $10.3B | $5.0B | $4.4B | $4.3B | $3.3B | $2.9B | $2.8B | $2.6B |
| Operating Income | $15.1B | $9.1B | $12.8B | $18.1B | $17.9B | $11.4B | $13.0B | $6.4B | $9.5B | $9.3B | $7.5B | $3.4B | $5.7B | $5.8B | $3.6B |
| Interest Expense | $2.9B | $2.8B | $2.2B | $2.2B | $2.4B | $2.5B | $1.8B | $1.3B | $1.1B | $1.0B | $719.0M | $429.0M | $299.0M | $104.0M | - |
| Income Tax | $2.4B | -$570.0M | $1.4B | $1.6B | $1.4B | -$1.2B | $544.0M | -$490.0M | $2.4B | $1.9B | $1.5B | $595.0M | $1.2B | $450.0M | $235.0M |
| Net Income | $4.2B | $4.3B | $4.9B | $11.8B | $11.5B | $4.6B | $7.9B | $5.7B | $5.3B | $6.0B | $5.1B | $1.8B | - | - | - |
| EPS (Basic) | $2.73 | $6.65 | $6.48 | $2.73 | $5.30 | $3.67 | $3.31 | $3.65 | $3.15 | $1.11 | $2.58 | $3.35 | $2.18 | $3.35 | $2.18 |
| EPS (Diluted) | $2.72 | $6.63 | $6.45 | $2.72 | $5.28 | $3.66 | $3.30 | $3.63 | $3.13 | $1.10 | $2.56 | $3.35 | $2.18 | $3.35 | $2.18 |
| Shares Outstanding | 1.8B | 1.8B | 1.8B | 1.7B | 1.5B | 1.5B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B |
| Gross Margin | - | - | - | - | - | - | - | 18.3% | 17.4% | 17.9% | 17.9% | 17.3% | 16.9% | - | - |
| Operating Margin | 24.6% | 16.2% | 23.5% | 31.2% | 31.9% | 24.8% | 39.0% | 19.5% | 33.8% | 36.4% | 33.0% | 17.1% | 30.1% | 31.6% | 20.8% |
| Profit Margin | 6.9% | 7.6% | 8.9% | 20.4% | 20.5% | 10.1% | 23.7% | 17.4% | 18.8% | 23.2% | 22.5% | 8.9% | - | - | - |